Progress of the treatment of diabetic nephropathy / 中国综合临床
Clinical Medicine of China
; (12): 547-551, 2017.
Article
en Zh
| WPRIM
| ID: wpr-613298
Biblioteca responsable:
WPRO
ABSTRACT
The treatment of diabetic nephropathy (DN) currently extent to control the occurrence and development of it and delay renal failure on a certain stage.However,the effect is not satisfactory.Some traditional hypoglycemic,antihypertensive,lipid and anticoagulant drugs in DN patients with renal protective effect.And some have been in clinical use of drugs such as vitamin D,aldose reductase inhibitors,tripterygium wilfordii glycoside has proved to have the effect of the slow progress in DN,could be used more widely.For new drugs,such as renin inhibitors,phosphodiesterase inhibitors and methyl bartholomew sauron,while partialy was confirmed in a role in the treatment of DN,but before the clinical promotion,its effectiveness and safety still need further study to verify.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
Clinical Medicine of China
Año:
2017
Tipo del documento:
Article